[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.
Purpose: The purpose of the present study is to evaluate safety, human radiation dosimetry, and optimal imaging time of [89Zr]trastuzumab in patients with HER2-positive breast cancer.Procedures: Twelve women with HER2-positive breast cancer underwent [89Zr]trastuzumab positron emission tomography (P...
| Published in: | Molecular Imaging & Biology Vol. 18; no. 6; pp. 952 - 960 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | clinical trial research Journal Article |
| Published: |
Springer Nature
Dec2016
|
| Online Access: | View this record in EBSCOhost |